Pure Global
NCT03268395

Correlation of CO2 Measured by Blood Gas vs Transcutaneous Monitor

The Correlation of CO2 Measured by SenTec Transcutaneous Monitoring With Arterial Blood Gas CO2 Levels in Neonates
Memorial Health University Medical Center·ClinicalTrials.gov·diagnostic test
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Respiratory Complication
Drug/Device/Intervention
Arterial Blood Gas and Transcutaneous CO2 Monitor
Study type
Interventional
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Memorial Health University Medical Center
Location
Savannah, United States of America
Timeline & enrollment
Phase
N/A
Start date
Aug 29, 2017
End date
Dec 30, 2018
Enrollment
266 participants
Primary outcome

Observed mean CO2 difference

Summary

The purpose of this clinical investigation is to compare transcutaneous CO2 (TCCO2) levels
 measured non-invasively using the SenTec Transcutaneous CO2 Monitor to PaCO2 levels measured
 on arterial blood gas (ABG) samples in neonatal patients being treated for respiratory
 distress in the Neonatal Intensive Care Unit (NICU) at Memorial University Medical Center.

ICD-10 classifications
Respiratory disorder, unspecifiedOther respiratory disordersRespiratory failure, unspecifiedOther postprocedural respiratory disordersOther specified respiratory disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT03268395
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT03268395 through Pure Global AI's free database. This phase not specified trial is sponsored by Memorial Health University Medical Center and is currently status unknown. The study focuses on Respiratory Complication. Target enrollment is 266 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.